M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Cancer immunotherapy innovator Jim Allison wins 2015 Paul Ehrlich and Ludwig Darmstaedter Prize
Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, received the 2015 Paul Ehrlich and Ludwig Darmstaedter Prize Saturday  in recognition of his work opening a completely new way to treat cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - March 16, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson study predicts new hepatitis C drugs will place a dramatic financial strain on the health care system
This study was finalized prior to FDA approval of AbbVie's HCV drug, and of Gilead's announcement that discounts on Sovaldi would be discounted up to 46 percent on average. In subsequent analysis using older discounts for 2014 and then applying the 46 percent discount for 2015 onward, Dr. Chhatwal predicts the budget needed would be $90 billion over five years (versus $136 billion). Compared with old drugs, new therapies would cost an additional $20 billion (versus $65 billion), with $16 billion in cost offsets.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - March 16, 2015 Category: Cancer & Oncology Source Type: news

Hippo 'Crosstalk' May Be Vital to Tumor Suppression
Scientists at MD Anderson Cancer Center have discovered new information about a key pathway known as Hippo, a metaphoric name referencing its link to tissue "overgrowth." (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - March 9, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Study Shows Why Some Brain Cancers Resist Treatment
Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - March 2, 2015 Category: Cancer & Oncology Source Type: news

Christopher Logothetis honored with inaugural Finneran Family Prize
The University of Texas MD Anderson Cancer Center has awarded the inaugural Finneran Family Prize to Christopher Logothetis, M.D., chair and professor of Genitourinary Medical Oncology. The $50,000 cash award will be given annually to a deserving faculty member through the Finneran Family Endowment in Translational Research at MD Anderson. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 27, 2015 Category: Cancer & Oncology Source Type: news

Anderson Algorithm increases surgical success with advanced ovarian cancer
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 27, 2015 Category: Cancer & Oncology Source Type: news

Andrew Futreal receives Jack and Beverly Randall Prize
The University of Texas MD Anderson Cancer Center has awarded Andrew Futreal, Ph.D., professor of Genomic Medicine, the inaugural Jack and Beverly Randall Prize for Excellence in Cancer Research. Futreal is recognized internationally as a pioneer in large-scale systematic cancer genomics, which led to the identification of the BRCA1 and BRCA2 breast/ovarian cancer susceptibility genes, BRAF mutations in melanoma, ERBB2 mutations in non-small cell lung cancer and multiple new cancer genes in renal cell carcinoma.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 26, 2015 Category: Cancer & Oncology Source Type: news

Alejandro Contreras and Yun Wu receive Shirley Stein Scientific Endowed Research Award
The University of Texas MD Anderson Cancer Center has awarded Alejandro Contreras, M.D., Ph.D., assistant professor of Pathology, and Yun Wu, M.D., Ph.D., associate professor of Pathology, the inaugural Shirley Stein Scientific Endowed Research Award. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 26, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Names Hwu as Head of Cancer Medicine
Patrick Hwu, M.D., chair of Melanoma Medical Oncology and Sarcoma Medical Oncology at The University of Texas MD Anderson Cancer Center, has been named division head of Cancer Medicine effective March 4. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 25, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Studies Skin Cancer Patients Resistant to Leading Therapy
Powerful drugs known as BRAF-inhibitors have been crucial for melanoma patients, saving lives through their ability to turn off the BRAF protein's power to spur cancer cell growth. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 23, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Receives $22.3 Million in CPRIT Research Funding
The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas (CPRIT). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 20, 2015 Category: Cancer & Oncology Source Type: news

Breast Cancer Spread May Be Tied to Cells That Regulate Blood Flow
Tumors require blood to emerge and spread. That is why scientists at The University of Texas MD Anderson Cancer Center believe that targeting blood vessel cells known as pericytes may offer a potential new therapeutic approach when combined with vascular growth factors responsible for cell death. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 19, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson presents second annual Making Cancer History® Seminar in Austin
Renowned oncologists from The University of Texas MD Anderson Cancer Center return to Austin March 5 for the institution's well-known Making Cancer History® educational seminar. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 19, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson to host childhood cancer awareness event, "Let the golden times roll"
The University of Texas MD Anderson Children's Cancer Hospital is hosting a Mardi Gras golden-themed childhood cancer awareness event honoring pediatric patients and families affected by childhood cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 13, 2015 Category: Cancer & Oncology Source Type: news

Scientist Receives Top Award in Physiology and Medicine
Raghu Kalluri, M.D., Ph.D., chair, cancer biology at The University of Texas MD Anderson Cancer Center, has received a notable scientific award from a top German university. Kalluri was selected for the Jacob-Henle Medal, awarded annually by the Georg-August University in Göttingen, Germany, one of that country's oldest institutions of higher learning.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - February 13, 2015 Category: Cancer & Oncology Source Type: news